Effects of heparin-induced lipolytic activity on the structure of rat high-density lipoprotein
- PMID: 2713384
- DOI: 10.1016/0005-2760(89)90348-2
Effects of heparin-induced lipolytic activity on the structure of rat high-density lipoprotein
Abstract
Following its secretion into the plasma compartment, the high-density lipoprotein (HDL) is presumed to be acted upon by both soluble enzymes, such as lecithin:cholesterol acyltransferase (LCAT), and membrane-associated enzymes, such as lipoprotein lipase and hepatic lipase. Rats were injected intravenously with heparin to release membrane-associated lipolytic activities into the circulation and the collected plasma was incubated overnight at 37 degrees C in the presence or absence of an LCAT inhibitor or an inhibitor of lipoprotein lipase (1 M NaCl). It was observed that lipoprotein lipase accounted for most of the triglyceride hydrolase activity in the heparin-treated plasma, and that the heparin-releasable activities caused an increase in HDL density but no measurable change in particle size when LCAT was inhibited. Heparin treatment caused about a 60% decrease in plasma triacylglycerol during the interval between injection of heparin and blood collection. Although this caused marked compositional changes in the d less than 1.063 g/ml lipoproteins, no changes were observed in the lipid composition or apoprotein distribution in the HDL. Subsequent incubation for 18 h at 37 degrees C produced marked increases in the apoE content of HDL from heparin-treated plasma even when LCAT was inhibited. Time-course studies showed that in the presence of an LCAT inhibitor there was considerable conversion of phosphatidylcholine to lysophosphatidylcholine in heparin-treated plasma, and that this activity was diminished by 1 M NaCl, but that no phospholipolysis was observed in control plasma. By contrast, both heparin-treated and control plasma possessed substantial triglyceride hydrolase activity. The concurrent action of lipases and LCAT was observed to reduce the maximum level of cholesterol esterification which could be achieved in the absence of lipase activity. It is concluded that changes in HDL particle size are mainly attributable to LCAT, but that lipase activities, which are either free in rat plasma or releasable by heparin, play a role in restructuring the phospholipid moiety and altering the protein composition of the HDL, especially with respect to apoE, a potential ligand to cellular receptors.
Similar articles
-
The rabbit as an animal model of hepatic lipase deficiency.Biochim Biophys Acta. 1989 Apr 3;1002(2):173-81. doi: 10.1016/0005-2760(89)90284-1. Biochim Biophys Acta. 1989. PMID: 2930766
-
An investigation of the role of lecithin:cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins.Atherosclerosis. 1991 Jul;89(1):35-48. doi: 10.1016/0021-9150(91)90005-n. Atherosclerosis. 1991. PMID: 1772470
-
Effect of intralipid infusion on lecithin:cholesterol acyltransferase and lipoprotein lipase in young rats.Biochim Biophys Acta. 1989 Feb 6;1001(2):145-9. doi: 10.1016/0005-2760(89)90140-9. Biochim Biophys Acta. 1989. PMID: 2492823
-
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.Clin Lab. 2003;49(11-12):601-13. Clin Lab. 2003. PMID: 14651331 Review.
-
Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism.Curr Opin Lipidol. 1995 Jun;6(3):130-5. doi: 10.1097/00041433-199506000-00004. Curr Opin Lipidol. 1995. PMID: 7648001 Review.
Cited by
-
HDL composition regulates displacement of cell surface-bound hepatic lipase.Lipids. 2008 Sep;43(9):793-804. doi: 10.1007/s11745-008-3214-1. Epub 2008 Aug 1. Lipids. 2008. PMID: 18670796
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous